July 2026

UROLOGY

PROTEUS TRIAL TAKEAWAYS: REDEFINING CARE FOR HIGH-RISK PROSTATE CANCER

As new data published in The New England Journal of Medicine reshape treatment discussions for high-risk localized prostate cancer, understanding the nuances behind the evidence is critical. Ashley E. Ross, MD, PhD, a member of the PROTEUS (Perioperative Treatment with Erleada United with Surgery) steering committee, offers an insider's perspective on the landmark trial, including how it’s adding options for standard of care.
Ashley E. Ross, MD, PhD, Clinical Director for the Polsky Urologic Cancer Center of Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Professor of Urology at Northwestern Medicine 

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like